PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients to Optimize Delivery of Systemic Therapy.

Inclusion Criteria:

* Adequate english to participate in focus groups and workshops without an interpreter
* Patients of the study site who are currently undergoing systemic therapy or have previously undergone systemic therapy within the past 12 months
* Patients willing to participate in at least 60-minute and ideally 90-minute workshops at the designated study location, time and date.
* Patients capable of providing informed consent before attending the first workshop

For carers

* Should be the primary carer nominated by a patient who fulfils the inclusion criteria, this includes parents of affected children
* Should be willing to participate in at least a 60-minute and ideally 90-minute workshops at the designated study location, time and date.
* Carers can only participate in the study with the cancer patient he/she is caring for. The patient has to also involved in the study
* Carers need to be capable of providing informed consent before attending the first workshop

For healthcare professionals

* All clinicians need to be current employees of the study site
* Doctors need to be employed at Specialist Registrar, Fellow or Consultant Level
* Nurses of all grades are invited to participate but ideally need to have had some involvement in the outpatient care of oncology patients

All participants:-

* Should be willing to have the session's recorded audio, transcripts and analysed data from the focus groups/workshops shared with Entia Ltd.
* should be willing to attend multiple 60 to 90 minute workshops.
* should be willing for photos and video footage to be taken during the interview.
* Participants attending workshops later in the development process must be comfortable consenting to finger prick testing/ assessing the ease of use of the test disposable

Exclusion Criteria:

For patients

* Does not have adequate English to participate in focus group interview without an interpreter
* Patients of the study site who are not currently undergoing systemic therapy or have previously undergone systemic therapy within the past 12 months
* Patients not willing to participate in at least 60-minute and ideally 90-minute focus group discussion at the designated study location, time and date.
* Participant not capable of providing consent or have a suitable, legally acceptable representative present to provide consent before the focus group interview.

For carers

* Is not the nominated primary carer of a cancer patient who fulfils the inclusion criteria, this includes parents of affected children
* Not paired with a patient that is involved in the study
* Carers not willing to participate in at least a 60-minute and ideally 90-minute focus group discussion at the designated study location, time and date.

For healthcare professionals

● Doctors who are not employed at Specialist Registrar, Fellow or Consultant Level